Explore the Pomegranate Health Podcast library
Browse all episodes below, starting with the most recent releases.
Latest episodes
[IMJ On-Air] DKA and insulin infusion protocols
There’s some variability in the way DKA is managed between Australian hospitals and the potential for added cognitive load on health practitioners moving between them. Is there enough evidence to settle on a consistent insulin infusion protocols?
[Case Report] 46yo with psychosis and cold intolerance
A 46 yo man is admitted with a florid experience of psychosis associated with occasional dizziness and an intolerance of cold. Physical examination reveals symptoms consistent with hypothyroidism but what could be the cause?
Ep102: Staying on script with semaglutide
Semaglutide has proven effectiveness for glycaemic control and weight loss as well as predictable benefits for cardiovascular and metabolic health. But the unprecedented demand from the wider population has posed a problem for regulators and prescribers.
[IMJ On-Air] Hyperglycaemia and COVID-19
In the first year of the COVID-19 pandemic, international studies showed that pre-existing diabetes conferred a significant mortality risk. Researchers have retrospectively examined electronic medical records in two Melbourne health services to find no such association.
Ep47: Complex Adolescent Transitions—Congress 2019
Adolescence is a turbulent time as teens are faced not just with changes to their bodies, but to their moods and thought patterns as well. Young people with complex needs such as diabetes, transplant management or intellectual disability are the least likely to received dedicated transition support. The three speakers in this podcast explain that improving this transition process doesn’t require going way above and beyond regular practice, it just needs a little more coordination. And all the medical care in the world needs to fit in with the lifestyle that every young adult aspires to.
Ep41: Targeting Diabetes
Glucose-lowering medications have been the mainstay of managing type 2 diabetes for 20 years. But a recent polemic between diabetes organisations has prompted an examination of specific targets for blood sugar in different patients. This episode explores the debate, and also summarises the use of new drug classes that don’t just lower blood glucose but appear to provide cardiovascular benefits directly in sicker patients.
Ep9: The Gut Microbiome and IBD
Understanding the gut microbiome offers potential new insight for treating a number of diseases—gastrointestinal and otherwise. But what’s the evidence base? This episode is presented in partnership with the Internal Medicine Journal.
Ep8: Obesity Inside Out
Obesity can seem like what strategists call a 'wicked problem'—a problem with so many parts that it's impossible to solve. But some things are changing.